CGMs Are Just Getting Started - What Comes Next?

Think about the systems we rely on every day - the ones we can’t afford to fail. We track them, measure them, and monitor them constantly. Satellites beam data every second to prevent disaster. Air traffic control maintains relentless vigilance on planes in the sky. Financial markets are monitored around the clock, every fluctuation tracked and analysed to avoid instability.

And yet, when it comes to our own bodies, we wait until something breaks before we even look under the hood.

This reactive approach isn’t just outdated - it’s reckless, and is proving costly. Chronic diseases don't appear overnight; they evolve over years. But instead of spotting them early, our healthcare system scrambles to play catch-up and (surprise, surprise!) we’re falling behind. One in three Americans has metabolic issues. Diabetes is officially a pandemic. Cardiovascular disease claims over 30% of lives worldwide. These conditions are, for the most part, preventable - yet we still treat them as inevitable.

We’re not just losing the battle; we’re barely showing up for the fight.

---

Here’s the Good News: CGMs Are Rewriting the Rules of Health

Continuous Glucose Monitors (CGMs) have been the first major shift in this reactive model. Originally designed to help people with diabetes, CGMs have shown something profound: that real time data drives behaviour change. When you can see how every meal, every workout, and even your sleep patterns affect your glucose levels, you start making different choices, and you see the results in real time. It’s a powerful feedback loop. Companies like ZOE and Levels have already demonstrated that glucose insights can drive long-term change, turning everyday decisions into opportunities for better health.

The global CGM market has skyrocketed in just a few years, growing from almost nothing to a multi-billion-dollar industry. Sure, a big chunk of that growth is tied to diabetes care, but glucose is only a piece of the puzzle. CGMs are evolving into something far more transformative - a gateway to personalised, 360-degree health monitoring.

---

Beyond Glucose: Toward Multi‑Molecule Monitoring

Imagine if your CGM could also show your cortisol climbing after a stressful day, or track ketones as your body switches from burning sugar to burning fat during a workout. Imagine being able to see inflammation markers tick upwards after a week of poor sleep, and adjusting before you even start to feel unwell.

This is multi-molecule monitoring: your body’s dashboard in real-time. And that next frontier is already under construction.

The breakthrough isn’t just about collecting more data; it’s about connecting the dots. Right now, most of us get a handful of biomarker readings from a blood test once or twice a year. Imagine a continuous stream of insights, captured every minute. That’s the magic of longitudinal and multi-analyte data: it will reveal patterns we've never seen. How stress hormones interact with blood sugar, how inflammation foreshadows metabolic dysfunction, or how recovery habits shape long-term endurance.

By tracking your body in real time over months and years, we can spot issues long before they become crises, uncover trends that predict future health risks, and deliver personalised interventions that address the root cause.

This level of proactive care was a pipe dream until now. We’re not quite there yet, but CGMs have given us a glimpse of what’s possible - laying the groundwork for a future where we don’t just monitor, but predict, prevent, and personalise care like never before.

---

A Proactive Revolution in Healthcare

The impact CGMs have had on diabetes management is huge, but we cannot just stop at that. The same technology is opening the door to continuous, multi-molecule health tracking that could reshape how we prevent and treat disease altogether.

This opens the door to a paradigm shift that is rewriting the playbook of health itself. A world where you won’t need to wonder what’s going on inside your body - you’ll know. And you’ll have the insights to act on it before problems arise.

The question now isn’t whether molecule monitoring will transform healthcare. It’s how fast we can make it happen, and how ready we are to step into that future.